Dr. Reeves is the President and Chief Medical Officer of AZTherapies. She has over twenty years of experience in Phase 1 through 4 drug development across multiple therapeutic areas, including neuroscience, oncology, immunology, and women’s health.
Most recently Dr. Reeves held the position of Vice President, Head Global Clinical Submissions Quality and Innovation, Worldwide Research and Development, Pfizer, Inc. At Pfizer, Dr. Reeves held multiple leadership positions in Worldwide Research and Development and Worldwide Regulatory and Safety, including Vice President, Neuroscience Clinical Development. Dr. Reeves has proven leadership in numerous successful global development programs and approvals, including three marketed drugs in neuroscience. Under her direct leadership, Chantix gained FDA Priority Review and won the Prix Galien Award for Best Pharmaceutical, considered to be the highest accolade in Pharmaceutical Research&Development and has been approved in more than 80 countries. Prior to her most recent position at Pfizer, Dr. Reeves was Vice President, Head Global Medical Science, at Estella’s Parma Global Development Inc.
Dr. Reeves has extensive experience in neurology and psychiatry both as a clinician drug developer and in business development and has publications in peer-reviewed journals. Dr. Reeves earned her B.A. from Yale University and her M.D. from the University of Vermont Medical School and has held faculty positions at Harvard Medical School and Tufts Medical School.